loading page

Ultrasound Based Three-Dimensional Mapping for Safely Performing Intracardiac Echocardiographic Left Atrial Appendage Occlusion Device Implantation.
  • +5
  • Mahmoud Elsayed,
  • Madhan Nellaiyappan,
  • Mark Doyle,
  • Laith Alhuneafat,
  • Colin Slemenda,
  • Emerson Liu,
  • David Lasorda,
  • Amit Thosani
Mahmoud Elsayed
Allegheny Health Network Cardiovascular Institute

Corresponding Author:[email protected]

Author Profile
Madhan Nellaiyappan
Allegheny Health Network Cardiovascular Institute
Author Profile
Mark Doyle
Allegheny Health Network Cardiovascular Institute
Author Profile
Laith Alhuneafat
Department of Internal Medicine Allegheny Health Network Allegheny General Hospital Pittsburgh Pennsylvania USA
Author Profile
Colin Slemenda
Allegheny Health Network Cardiovascular Institute
Author Profile
Emerson Liu
Division of Cardiac Electrophysiology Department of Cardiology Allegheny General Hospital Allegheny Health Network Pittsburgh Pennsylvania USA
Author Profile
David Lasorda
Allegheny Health Network Cardiovascular Institute
Author Profile
Amit Thosani
Division of Cardiac Electrophysiology Department of Cardiology Allegheny General Hospital Allegheny Health Network Pittsburgh Pennsylvania USA
Author Profile

Abstract

Background: Left atrial appendage occlusion (LAAO) has historically been performed using intraprocedural transesophageal echocardiography (TEE) and fluoroscopy. Multiple recent reports have described the feasibility and advantages of utilizing two-dimensional intracardiac echocardiography (ICE) for LAAO. However, in inexperienced hands, safe manipulation of the ICE catheter in the left atrium (LA) can be challenging. Objective: To assess the feasibility and efficacy of three-dimensional (3D) ICE mapping in guiding LAAO device implant compared to standard TEE imaging. Methods: We retrospectively included patients who underwent LAAO in our institution from January 2017 and October 2021. We compared baseline demographics, intraprocedural data, post-procedural complications, and outcomes. P= value of <0.05 was considered significant. A linear regression model was performed using ICE and TEE as dependent variables to model contrast dose. Results: 130 patients underwent LAAO device implantation, of which 57 underwent ICE guided LAAO and 73 underwent TEE guided implantation. There was no difference in baseline demographics or post-procedural outcomes between both groups. There was no difference in the total procedure time between ICE and TEE groups, 86 (72-107) and 83 (72-111) minutes (p=0.65), respectively. Conversely, total fluoroscopic time was significantly shorter in ICE arm 7.8 (5.6-11), compared to TEE arm 12.9 (10.5-17.6) (p= <0.001). In patients undergoing LAAO device implantation using 3D ICE technique, with each additional ICE-guided procedure, the contrast dose decreased by 0.87 mL (correlation r = -0.48, p<0.001). Conclusion: 3D ICE is safe and feasible in guiding LAAO device implantation. When compared to TEE technique, total fluoroscopic time was shorter. Additionally, with more procedures utilizing 3D ICE, contrast dose decreased in a linear fashion.